Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Haleon to invest Rs 2,000 crore to set up first India plant
Haleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fast-growing consumer healthcare market. The plant will produce oral-health products, including Sensodyne. It aims to reach one billion more consumers by 2030, with 300 million in India. The facility will also cater to export markets.
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
Analysts lift bets on India Inc after strong March quarter
Analysts have upgraded earnings estimates for a majority of NSE 500 companies following better-than-expected profit growth in the March 2026 quarter. This surge in upgrades, particularly for sectors like banking, capital goods, and healthcare, is driven by strong performance and favorable market conditions. The quantum of earnings revisions also saw a significant increase, with many companies receiving substantial upward adjustments.
Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supply
Uzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbekistan a key hub for making and supplying medicines in the region. Simplified rules and tax benefits will encourage more investment. This move will boost local healthcare and strengthen trade ties between the two nations.
Upcoming IPO? Paras Healthcare Files Draft Papers With SEBI To Raise Rs 1,800 Crore Via IPO
Paras Healthcare IPO: The total offer size is up to Rs 1,800 crore.
CMR Green IPO subscribed 127x; Paras Healthcare files for ₹1,800-cr IPO
CMR Green's IPO was subscribed 127 times, boosting hopes of a primary market revival as Sebi cleared five new IPOs and Paras Healthcare filed draft papers
Sensex sheds 117 points after RBI policy; healthcare stocks buck trend
The S&P BSE Sensex declined 116.67 points or 0.16% to 74,243.34. The Nifty 50 index slipped 49.85 points or 0.21% to 23,366.70.
Market ends with minor cuts; Nifty settles below 23,400 level
The Nifty settled below the 23,400 mark. Metal, IT and oil & gas stocks witnessed selling pressure, while media, healthcare and realty shares attracted buying interest.
Paras Healthcare IPO: Company files DRHP with SEBI to raise ₹1,800 crore via public issue
The proposed IPO comprises a fresh issue of equity shares aggregating up to ₹500 crore and an offer for sale (OFS) of shares worth up to ₹1,300 crore by the selling shareholder, taking the total issue size to up to ₹1,800 crore.
Paras Healthcare plans ₹1,800 crore IPO, files draft papers with Sebi
Paras Healthcare Ltd, which operates hospitals under the 'Paras Health' brand, has filed preliminary papers with capital markets regulator Sebi to raise up to Rs 1,800 crore through an initial public offering (IPO). The proposed IPO comprises a fresh issue of equity shares aggregating up to Rs 500 crore and an Offer-For-Sale (OFS) of equity shares worth up to Rs 1,300 crore by the selling shareholder, according to the draft red herring prospectus (DRHP) filed on Thursday. Those selling shares include promoter Dharminder Kumar Nagar and other investors. The Gurugram-based company intends to utilise the proceeds from the fresh issue towards prepayment or repayment of certain outstanding borrowings, investment in its wholly-owned subsidiary PMHPL for its debt payment, and for general corporate purposes. Paras Healthcare is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through a network of eight hospitals with an aggregate capacity of
Savings Scheme, Succession Planning Among Perks Offered By UAE Firms To Retain Employees
For years, employee benefits have centred around immediate needs like healthcare and insurance.
Manipal Health picks up hospital building in Bengaluru through 30-year lease
Manipal Health Enterprises has secured a large hospital building in Bengaluru's Yelahanka area. The lease spans nearly 30 years, with total rental payments projected at over Rs 816 crore. This move signifies the hospital chain's ongoing expansion across major Indian cities. The transaction underscores the growing trend of healthcare operators prioritizing long-term occupancy in prime urban markets.